Differential Gene Expression of Subcutaneous Adipose Tissue among Lean, Obese, and after RYGB (Different Timepoints): Systematic Review and Analysis
Open Access
Abstract
The main roles of adipose tissue include triglycerides storage and adipokine secretion, which regulate energy balance and inflammation status. In obesity, adipocyte dysfunction leads to proinflammatory cytokine production and insulin resistance. Bariatric surgery is the most effective treatment for obesity, the gold-standard technique being Roux-en-Y gastric bypass (RYGB). Since metabolic improvements after RYGB are clear, a better understanding of adipose tissue molecular modifications could be derived from this study. Thus, the aim of this systematic review was to find differentially expressed genes in subcutaneous adipose tissue of lean, obese and post-RYGB (distinct timepoints). To address this objective, publications from 2015–2022 reporting gene expression (candidate genes or transcriptomic approach) of subcutaneous adipose tissue from lean and obese individuals before and after RGYB were searched in PubMed, Elsevier, and Springer Link. Excluded publications were reviews, studies analyzing serum, other types of tissues, or bariatric procedures. A risk-of-bias summary was created for each paper using Robvis, to finally include 17 studies. Differentially expressed genes in post-RYGB vs. obese and lean vs. obese were obtained and the intersection among these groups was used for analysis and gene classification by metabolic pathway. Results showed that the lean state as well as the post-RYGB is similar in terms of increased expression of insulin-sensitizing molecules, inducing lipogenesis over lipolysis and downregulating leukocyte activation, cytokine production and other factors that promote inflammation. Thus, massive weight loss and metabolic improvements after RYGB are accompanied by gene expression modifications reverting the “adipocyte dysfunction” phenomenon observed in obesity conditions.Keywords
Funding Information
- Proyectos de Investigación e Innovación Tecnológica (IA203919, HIM/2018/028 SSA. 1494, 289699)
- Dirección General de Asuntos del Personal Académico (DGAPA) (IA203919, HIM/2018/028 SSA. 1494, 289699)
- Universidad Nacional Autónoma de México (UNAM) (IA203919, HIM/2018/028 SSA. 1494, 289699)
- División de Investigación de la Facultad de Medicina, UNAM (IA203919, HIM/2018/028 SSA. 1494, 289699)
- Hospital Infantil de México Federico Gómez (IA203919, HIM/2018/028 SSA. 1494, 289699)
- CONACYT-FOSSIS (IA203919, HIM/2018/028 SSA. 1494, 289699)
This publication has 93 references indexed in Scilit:
- The immune cells in adipose tissueDiabetes, Obesity and Metabolism, 2013
- Overexpressed FATP1, ACSVL4/FATP4 and ACSL1 Increase the Cellular Fatty Acid Uptake of 3T3-L1 Adipocytes but Are Localized on Intracellular MembranesPLOS ONE, 2012
- Adipose tissue remodeling and obesityJournal of Clinical Investigation, 2011
- Characterizing the profile of obese patients who are metabolically healthyInternational Journal of Obesity, 2010
- Adipose tissue remodeling in pathophysiology of obesityCurrent Opinion in Clinical Nutrition and Metabolic Care, 2010
- The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe ObesityPLOS ONE, 2010
- PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid MetabolismPLOS Genetics, 2007
- Adiponectin modulates inflammatory reactions via calreticulin receptor–dependent clearance of early apoptotic bodiesJournal of Clinical Investigation, 2007
- Search for the preadipocyte progenitor cellJournal of Clinical Investigation, 2006
- Role of Hck in the Pathogenesis of Encephalomyocarditis Virus-Induced Diabetes in MiceJournal of Virology, 2001